rs76106850
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_001367721.1(CASK):c.1922G>A(p.Arg641Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000167 in 1,203,462 control chromosomes in the GnomAD database, including 1 homozygotes. There are 74 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00012 ( 1 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.00017 ( 0 hom. 70 hem. )
Consequence
CASK
NM_001367721.1 missense
NM_001367721.1 missense
Scores
2
2
13
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
CASK (HGNC:1497): (calcium/calmodulin dependent serine protein kinase) This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CASK. . Gene score misZ 4.2502 (greater than the threshold 3.09). GenCC has associacion of gene with syndromic X-linked intellectual disability Najm type, X-linked syndromic intellectual disability, developmental and epileptic encephalopathy, FG syndrome 4.
BP4
Computational evidence support a benign effect (MetaRNN=0.016835362).
BP6
Variant X-41553836-C-T is Benign according to our data. Variant chrX-41553836-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 166794.We mark this variant Likely_benign, oryginal submissions are: {Benign=4, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000116 (13/111723) while in subpopulation EAS AF= 0.00308 (11/3576). AF 95% confidence interval is 0.00172. There are 1 homozygotes in gnomad4. There are 4 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASK | NM_001367721.1 | c.1922G>A | p.Arg641Lys | missense_variant | 21/27 | ENST00000378163.7 | NP_001354650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASK | ENST00000378163.7 | c.1922G>A | p.Arg641Lys | missense_variant | 21/27 | 5 | NM_001367721.1 | ENSP00000367405 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 13AN: 111669Hom.: 1 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33849
GnomAD3 genomes
AF:
AC:
13
AN:
111669
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33849
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000224 AC: 41AN: 183137Hom.: 1 AF XY: 0.000251 AC XY: 17AN XY: 67623
GnomAD3 exomes
AF:
AC:
41
AN:
183137
Hom.:
AF XY:
AC XY:
17
AN XY:
67623
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000172 AC: 188AN: 1091739Hom.: 0 Cov.: 28 AF XY: 0.000196 AC XY: 70AN XY: 357275
GnomAD4 exome
AF:
AC:
188
AN:
1091739
Hom.:
Cov.:
28
AF XY:
AC XY:
70
AN XY:
357275
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000116 AC: 13AN: 111723Hom.: 1 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33913
GnomAD4 genome
AF:
AC:
13
AN:
111723
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33913
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
23
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2020 | This variant is associated with the following publications: (PMID: 31139143) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 09, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | CASK: PP2, BS1, BS2 - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Intellectual disability, CASK-related, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;.;.;.;.;.;.;T;.;.;.;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;N;.;.;.;N;.;.;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;.;.;.;.;N;.;N;.;.;.;.;.;.;.
REVEL
Benign
Sift
Benign
.;.;.;.;.;T;.;T;.;.;.;.;.;.;.
Sift4G
Benign
.;.;.;.;.;T;.;T;.;.;.;.;.;.;.
Polyphen
B;B;.;B;.;B;.;B;.;.;.;.;.;.;.
Vest4
0.50
MutPred
0.53
.;.;.;Gain of methylation at R641 (P = 0.0345);.;.;.;Gain of methylation at R641 (P = 0.0345);.;.;.;.;.;.;.;
MVP
0.76
MPC
1.1
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at